ARID1A represents a particularly interesting amiR-4 target since its deletion/mutation sensitises ovarian cancer cells to EZH2 methyltransferase inhibition with the small molecule GSK126 in a synthetic lethal fashion24. The gene discussed is EZH2; the disease is ovarian cancer.